Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dextroamphetamine
(S)-1-phenyl-2-aminopropane
(S)-amphetamine
Dextroamphetamine saccharate
d-amphetamine
(S)-1-phenyl-2-propylamine
Dexamfetamine
Dexamfetamina
Desamfetamina
Dextroamphetamine adipate
Dexanfetamina
(αS)-α-methylbenzeneethanamine
Dexamphetamine
Dextroamphetamine sulfate
(+)-(S)-amphetamine
(S)-α-methylbenzeneethanamine
(+)-α-methylphenylethylamine
Dexamfetaminum
(+)-amphetamine
(S)-(+)-amphetamine
(S)-(+)-β-phenylisopropylamine
(+)-α-methylphenethylamine
Brand Names
Mixed Salts of a Single Entity Amphetamine Product XR
Dexedrine
Teva-dextroamphetamine SR
Dextroamphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Adderall
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
